About
Embolotherapy devices
Areas of Focus
Categories
Uncategorized Medical Device
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
40
By Phase
NA: 3
By Status
COMPLETED: 3UNKNOWN: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT04267445Collaborator
Evaluate the Safety and Effectiveness of Using Echogenic Embolic Agent for Embolization of Prostate Artery for Treatment of Men With BPH (PAE CEUS)
N/AUnknown
15 participants
Started: Mar 31, 2020 · Completed: Mar 31, 2023
NCT03427671Lead Sponsor
OCL 500 Treatment of Women With Symptomatic Uterine Fibroids
NACompleted
12 participants
Started: Jan 17, 2018 · Completed: Sep 3, 2019
NCT02509975Lead Sponsor
Safety and Efficacy of OCL 503 in Prostate Artery Embolization
NACompleted
10 participants
Started: Sep 30, 2015 · Completed: May 31, 2018
NCT02410018Lead Sponsor
Safety and Effectiveness of OCL 503 in the Treatment of Women With Leiomyomata
NACompleted
3 participants
Started: Apr 30, 2015 · Completed: Jun 30, 2016
Locations (1)
Headquarters
Edmonton, AB, Canada
Map
Loading map...